Platelet function studies in myeloproliferative neoplasms patients with or mutation.

Background: and mutations are the most frequent molecular causes of -negative myeloproliferative neoplasms (MPN). Patients with mutations are at lower risk of thrombosis than patients with . We hypothesized that -mutated blood platelets would have platelet function defects that might explain why these patients are at lower risk of thrombosis.